Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NSD2 | O96028 | 1/20 | 0.60 |
| ▸ | ACLY | P53396 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.55 |
| ▸ | AGER | Q15109 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | KDM4A | O75164 | 2/20 | 0.54 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.54 |
| ▸ | KDM6B | O15054 | 1/20 | 0.54 |
| ▸ | KDM6A | O15550 | 1/20 | 0.54 |
| ▸ | TET3 | O43151 | 1/20 | 0.54 |
| ▸ | KDM4B | O94953 | 1/20 | 0.54 |
| ▸ | KDM5C | P41229 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29550511 | 1.00 | NSD2 (0.60) | NSD2ACLYKDM4ETDP1L3MBTL1 | |
| SCHEMBL28727190 | 0.98 | NSD2 (0.59) | NSD2ACLYKDM4ETDP1L3MBTL1 | |
| SCHEMBL5680479 | 0.98 | NSD2 (0.59) | NSD2ACLYKDM4ETDP1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL5450942 | 0.98 | NSD2 (0.59) | NSD2ACLYKDM4ETDP1L3MBTL1 | |
| SCHEMBL5680469 | 0.98 | NSD2 (0.59) | NSD2ACLYKDM4ETDP1L3MBTL1 | |
| Formaldehyde SCHEMBL27690889 | 0.96 | NSD2 (0.57) | NSD2ACLYKDM4ETDP1L3MBTL1 | |
| Acetic Acid SCHEMBL27656229 | 0.95 | NSD2 (0.56) | NSD2ACLYKDM4ETDP1L3MBTL1 | |
| Aziridine SCHEMBL27648195 | 0.92 | NSD2 (0.54) | NSD2ACLYKDM4ETDP1L3MBTL1 | |
| Alcohol SCHEMBL28316967 | 0.92 | NSD2 (0.57) | NSD2ACLYKDM4ETDP1L3MBTL1 | |
| Quinoline SCHEMBL27803388 | 0.92 | NR4A1 (0.58) | NSD2ACLYKDM4ETDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 638 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122013223-A | Bimetallic MOFs catalyst for synthesizing ammonia through electrocatalytic nitrate reduction and preparation method and application thereof | 东华大学 | 2026-05-12 | — | — | CN | claimed |
| WO-2025202864-A1 | ENT1 INHIBITORS IN COMBINATION WITH ONCOLYTIC VIRUSES AND THEIR USE IN THE TREATMENT OF CANCER | iTeos Belgium SA (BE) | 2025-10-02 | — | — | WO | claimed |
| WO-2025126110-A1 | ENT1 INHIBITORS IN COMBINATION WITH BISPECIFIC ANTIBODIES | iTeos Belgium SA (BE) | 2025-06-19 | — | — | WO | claimed |
| CN-119735483-B | Ethylene gas treatment method, polyolefin elastomer and preparation method thereof | 合肥中科科乐新材料有限责任公司 | 2025-05-30 | — | — | CN | claimed |
| WO-2025104613-A1 | ENT1 INHIBITORS IN COMBINATION WITH CHECKPOINT INHIBITORS | iTeos Belgium SA (BE) | 2025-05-22 | — | — | WO | claimed |
| CN-119841727-A | Method for directly preparing carboxylic ester compound from aromatic aldehyde, ketone and carboxylic acid | 湖南第一师范学院 | 2025-04-18 | — | — | CN | claimed |
| CN-119735483-A | Ethylene gas treatment method, polyolefin elastomer and preparation method thereof | 合肥中科科乐新材料有限责任公司 | 2025-04-01 | — | — | CN | claimed |
| CN-117797299-B | Bacteriostatic agent, bacteriostatic paper diaper and preparation method of bacteriostatic paper diaper | 杭州千芝雅卫生用品有限公司 | 2024-11-22 | — | — | CN | claimed |
| EP-4405369-A2 | A CIS-PLATINUM(II)-OLIGOMER HYBRID | Dublin City University (IE) | 2024-07-31 | — | — | EP | claimed |
| US-20240246060-A1 | Method Of Manufacture And Scale-Up Of The Metal-Organic Framework Cu(Qc)2 | ExxonMobil Technology and Engineering Company | 2024-07-25 | — | — | US | claimed |
| WO-2008152099-A2 | ARYL/HETARYLAMIDES AS MODULATORS OF THE EP2 RECEPTOR | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-12-18 | — | — | WO | claimed |
| WO-2008081399-A2 | 2-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2008-07-10 | — | — | WO | claimed |
| US-20080153837-A1 | Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof | AVENTIS PHARMA S.A. (FR) | 2008-06-26 | — | — | US | claimed |
| CN-100393720-C | Cyclic benzimidazoles. | ALTANA PHARMA AG (DE) | 2008-06-11 | — | — | CN | claimed |
| US-20070185148-A1 | M3 muscarinic acetylchoine receptor antagonists | GLAXO GROUP LIMITED (GB) | 2007-08-09 | — | — | US | claimed |
| EP-1725238-A2 | M 3 MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2006-11-29 | — | — | EP | claimed |
| CN-1784401-A | Novel fused triazolones and uses thereof | ASTRAZENECA AB (SE) | 2006-06-07 | — | — | CN | claimed |
| WO-2005094251-A2 | M3MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2005-10-13 | — | — | WO | claimed |
| US-20030044399-A1 | Method of treatment | SMITHKLINE BEECHAM CORPORATION | 2003-03-06 | — | — | US | claimed |
| CN-1047081-A | Antiseptic-germicide is with the manufacture method of composition and wherein used pyrroloquinoline derivative | OTSUKA PHARMA CO LTD (JP) | 1990-11-21 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030044399-A1 | Method of treatment | DNPEP, PEPD, ANPEP | NSD2 2962/4885ACLY 826/4885KDM4E 956/4885 |
| US-20070185148-A1 | M3 muscarinic acetylchoine receptor antagonists | CHRM3, CHRM2, CHRM5 | NSD2 3459/4885ACLY 724/4885KDM4E 4650/4885 |
| US-20080153837-A1 | Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof | HSP90B1, HSP90AB1, HSP90AA1 | NSD2 2475/4885ACLY 3509/4885KDM4E 3419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.